A real study assessing daratumumab in patients with relapsing or refractory multiple myeloma
Latest Information Update: 10 Jan 2021
At a glance
- Drugs Carfilzomib (Primary) ; Bortezomib; Dexamethasone; Pomalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 10 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology